We found that when the KLF6 gene is highly expressed, the probability of patients surviving more than 2,000 days is significantly lower than that of the KLF6 medium- to low-expression group, which indicates that the expression level of KLF6 may be negatively correlated with the survival rate of ovarian cancer (p < 0.05). Here, KLF6 is linked to ovarian cancer.